Compile Data Set for Download or QSAR
Report error Found 19 Enz. Inhib. hit(s) with all data for entry = 13488
TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798337BDBM798337(US20260078129, Compound Oclacitinib)
Affinity DataIC50: 12.9nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798339BDBM798339(US20260078129, Compound T1-B)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798338BDBM798338(US20260078129, Compound T1-A)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798341BDBM798341(US20260078129, Compound T2-A)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798350BDBM798350(US20260078129, Compound T3-B)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798366BDBM798366(US20260078129, Compound T4-A)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798374BDBM798374(US20260078129, Compound T5-D)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798373BDBM798373(US20260078129, Compound T5-C)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798400BDBM798400(US20260078129, Compound T6-B)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798384BDBM798384(US20260078129, Compound T6-A)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798414BDBM798414(US20260078129, Compound T7)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798407BDBM798407(US20260078129, Compound T6-C)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798416BDBM798416(US20260078129, Compound T8-B)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798415BDBM798415(US20260078129, Compound T8-A)
Affinity DataIC50: 100nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798343BDBM798343(US20260078129, Compound T2-B)
Affinity DataIC50: 550nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798348BDBM798348(US20260078129, Compound T3-A)
Affinity DataIC50: 550nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798370BDBM798370(US20260078129, Compound T4-B)
Affinity DataIC50: 550nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798372BDBM798372(US20260078129, Compound T5-B)
Affinity DataIC50: 550nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Felicamed Biotechnology Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 798371BDBM798371(US20260078129, Compound T5-A)
Affinity DataIC50: 550nMAssay Description:The ability of compounds to antagonize human A2A and A2B adenosine receptors was determined using a kit to measure changes in intracellular cyclic AM...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent